Ca2+-ATPase activity in human red cell membranes is dependent on the presence of calmodulin. All trans-retinoic acid inhibited human red cell membrane Ca2+-ATPase activity in vitro in a concentration-dependent manner (10-8 to 10-4 M). In contrast, retinol, retinal, 13-cis-retinoic acid and the benzene ring analogue of retinoic acid did not alter enzyme activity. Purified calmodulin (up to 500 ng/ml, 3 X 10-8 M) added to red cell membranes, in the presence of inhibitory concentrations of retinoic acid, only partially restored Ca2'-ATPase activity. 125I-Calmodulin bound to red cell membranes was displaced by unlabeled retinoic acid (50% reduction at 10-8 M retinoic acid), as effectively as by unlabeled calmodulin. Another calmodulin-stimulable enzyme, bovine brain cyclic nucleotide phosphodiesterase, was unaffected by retinoic acid. 8-Anilino-l-naphthalene sulfonic acid bound to calmodulin, studied spectrofluorometrically, was not displaced by retinoic acid. Thus, retinoic acid inhibits calmodulin binding to red cell membranes, reducing calmodulin-stimulable Ca2+-ATPase activity. Retinoic acid does not directly interact with calmodulin, but rather exerts its effect by interfering with calmodulin access to the membrane enzyme. These effects occur at physiological concentrations of the retinoid. (J. Clin. Invest. 1990Invest. . 85:1999Invest. -2003 retinoic acid * calmodulin * Ca2+-ATPase
Introduction
Calmodulin is a ubiquitous intracellular Ca2--binding protein (1) among whose functions are regulation of the activities of plasma membrane Ca2+-stimulated, Mg2e'-dpendent adenosine triphosphatase (Ca2+-ATPase'; EC 3.6.1.3) (2), cytoplasmic cyclic nucleotide phosphodiesterase (3) and certain protein kinases (4) . Calmodulin possesses discrete domains including binding sites for Ca2+ (5) and several hydrophobic sites at which it interacts with target enzymes (6) . Calmodulin antagonists are thought to bind to the hydrophobic site(s), although the interaction could occur elsewhere and allosterically affect enzyme activation by calmodulin.
Our laboratory has described the susceptibility of human red cell membrane Ca2+-ATPase to stimulation in vitro by physiological concentrations of thyroid hormone (7, 8) . This action of thyroid hormone and its analogues requires the presence of calmodulin (9) , but the hormone and calmodulin do not interact directly in this system (10) . Recently, we reported that retinoic acid blocks the activation by thyroid hormone of human erythrocyte Ca2+-ATPase (1 1) . This action has stringent stereochemical requirements; retinol, retinal and 13-cisretinoic acid all failed to mimic all-trans-retinoic acid (12) . The mechanism by which retinoic acid interferes with thyroid hormone action at the plasma membrane Ca2+-ATPase depends upon competition between retinoic acid and L-thyroxine (T4) or 3,5,3'-L-triiodothyronine (T3) for hormone-binding sites on the red cell membrane (12) . However, retinoic acid also inhibits Ca2+-ATPase activity in the absence of thyroid hormone (1 1 Binding of '25I-calmodulin to erythrocyte membranes. Red cell membranes (1.0 mg/ml), retinoic acid or retinol, and tracer 125IIcal-modulin, 6 X 10-2 M in 10 mM Tris HC1 buffer, were incubated for 60 min at 370C. The bound/free partition ofradiocalmodulin between red cell membranes and buffer was then effected by centrifugation (20,000 g X 20 min), as we have previously described with myocardial membranes (13) . In the absence of unlabeled calmodulin or retinoid, membranes bound 9% of tracer (3.3% was specific, and 5.7% nonspecific binding). Unlabeled calmodulin was added in 10 mM Tris in concentrations from 10-9 to 10-6 M. Retinoic acid and retinol (final concentrations, 10-1' to 10-6 M) were added to membrane aliquots with a final ethanol concentration of 1%.
Displacement of8-anilino-l-naphthalene sulfonic acid (ANS) from calmodulin by retinoic acid. The Ca2"-dependent binding of ANS to calmodulin was determined from the increase in fluorescence emission of the dye that accompanies its binding to calmodulin (14, 15) . Fluorescence was determined in a spectrofluorometer (SLM 8000; Aminco Corp., Urbana, IL) using an excitation wavelength of 340 nm and scanning fluorescence emission from 400 to 600 nm. Calmodulin (10-6 M) was incubated with ANS, 10-5 M, in 50 mM Tris HC1, pH 7.4, and EGTA, I mM. The Ca2"-dependent binding of ANS to calmodulin was taken as the increase in fluorescence signal associated with addition of CaCl2, 1.5 mM, to the above buffer. ANS displacement was determined in the presence of retinoic acid (concentrations ranging from 1-5 X 10-6 M) or diluent (0.1-0.5% ethanol) in control samples.
Assay of calmodulin-dependent cyclic nucleotide phosphodiesterase. Phosphodiesterase activity was determined by the method of Schaeffer et al. (16) with inorganic phosphate determined by the malachite green assay (17) . Calmodulin-dependent activity was defined as the difference in enzyme activity in samples lacking and containing calmodulin, 1.2 X 10-8 M, and was expressed as nanomoles Pi/minute.
Retinoic acid, or its diluent ethanol in a final concentration of 1%, was added to the assay mixture before initiation of the reaction.
Statistical analysis. Data were analyzed by paired t test or one-way analysis of variance (ANOVA).
Results
Red cell Ca2+-ATPase activity; effect of retinoids. Control Ca2`-ATPase activity was 0.387±0.014 ,umol Pi per mg protein per 90-min assay period. All trans-retinoic acid, 10-10 to M, caused a dose-dependent reduction in enzyme activity ( Fig.  1) : 26% reduction by 10-8 M and 51% by 10-6 M (P < 0.001, ANOVA). As the figure demonstrates, retinol, retinal, and 13- cis-retinoic acid in the same concentrations had no effect on enzyme activity. The benzene ring-substituted analogue of retinoic acid, RO 8-8717, did not inhibit Ca2+-ATPase activity (99% of control enzyme activity in the presence of 10-6 M analogue).
Effect ofpurified calmodulin on membrane Ca;2-ATPase activity in the presence of retinoids. Purified calmodulin, 6 X 10-9 M (100 ng/ml), when added to membranes for 60 min at 37°C, maximally stimulated red cell Ca2+-ATPase activity (Fig. 2) . In the presence of 10-9 and 10-8 M retinoic acid, there was a reduction in maximal enzyme activity achieved with the addition of calmodulin, as well as a shift in the calmodulin dose-response curve to the right; thus, in the presence of 10-8 M retinoic acid, maximal stimulation of the enzyme was seen with 1.2 X 10-8 M calmodulin. Retinol had no effect on enzyme stimulation by calmodulin at either concentration. The effect of retinoic acid on binding ofcalmodulin to red cell membranes. Both retinoic acid and unlabeled calmodulin significantly reduced membrane binding of 125I-calmodulin (6 X 10-12 M, P < 0.001, ANOVA), with 50% reduction in binding at concentrations of 1.1 and 2.5 X 10-8 M, respectively (Fig. 3) . Nonspecific binding of calmodulin to membranes was 63% of total calmodulin binding, as determined by incubation of 125-Icalmodulin in the presence of 10-6 M unlabeled calmodulin. Retinol did not displace radiolabeled calmodulin from red cell membranes (data not shown).
ANS-binding to calmodulin in the presence ofretinoic acid. The calcium-dependent binding of ANS to calmodulin was accompanied by an increase in fluorescence emission intensity and a shift of the emission maximum from 520 to 500 nm. The fluorescence emission spectrum of calmodulin-bound ANS was virtually unchanged in the presence of 1, 2, and 5 X 10-6 M retinoic acid (Fig. 4, top) . The slight apparent increase in fluorescence seen at the highest concentration of the retinoid is attributable to light scattering by the sample. In contrast, the addition of identical concentrations of the compound W-7, a well-characterized calmodulin antagonist (I8), resulted in a dose-dependent reduction in ANS fluorescence as this agent displaced ANS from calmodulin (30% decrease at 5 X 10-6 M W-7, Fig. 4, bottom) . Retinoic acid also failed to alter the fluorescence emission spectrum of dansyl-calmodulin (data not shown).
Effect ofretinoic acid on phosphodiesterase activity. Phosphodiesterase activity was stimulated threefold by the addition 
Discussion
Retinoids have important roles in the regulation ofgrowth and differentiation in normal and transformed epithelial and nonepithelial cells (19, 20) . The mechanisms of the actions of retinoic acid and its parent, retinol, appear to be nuclear (21, 22) as well as extranuclear (23) . In the present studies we have shown that retinoic acid, but not retinol, is a "calmodulin antagonist" in the context of the activation of human red cell Ca2+-ATPase by calmodulin. The evidence for the anti-calmodulin action of this retinoid includes (a) reduction of basal activity of Ca2+-ATPase, presumably reflecting antagonism of residual endogenous calmodulin bound to red cell ghosts (9), (b) an alteration in the V. for calmodulin stimulation in the presence of inhibitory concentrations of retinoic acid and (c) competition between retinoic acid and calmodulin for human red cell membrane binding sites.
Studies of the mechanism by which retinoic acid inhibits calmodulin's stimulation of Ca2+-ATPase, however, revealed that the retinoid was not a conventional calmodulin antagonist in that it did not directly interact with this Ca2+-binding protein. Spectrofluorometric assessment of ANS-binding to purified calmodulin indicated that retinoic acid and ANS did not compeLe for sites on that protein and stimulation by calmodulin of purified cyclic nucleotide phosphodiesterase activity was not inhibited by retinoic acid. Several laboratories, including our own, have shown that ANS interacts with calmodulin at more than one site (15, 24, 25) , including the hydrophobic region on the Ca2l-binding protein that is critical to phosphodiesterase and plasma membrane Ca2'-ATPase activity. Thus, the ANS-calmodulin model was an appropriate one with which to determine whether the calmodulin antagonism of retinoic acid reflected a direct interaction of the retinoid with calmodulin. Since retinoic acid did not affect the ANS-calmodulin complex, but inhibited calmodulin's binding to red cell membranes, we concluded that the inhibition by retinoic acid of calmodulin's stimulation of Ca2'-ATPase is membrane-mediated, at the membrane calmodulin-binding site involved in Ca2+-ATPase stimulation. The fact that retinol, retinal, and 13-cis retinoic acid had no anticalmodulin action supports the biologic specificity of action of retinoic acid at the plasma membrane, and furthermore attests to the divergence of actions of retinol and retinoic acid recognized previously, related to spermatogenesis and vision (26, 27) .
Evidence for the existence of a membrane calmodulin binding site has been developed in our laboratory (13) and by others (2, 28) . The possibility has not been excluded, however, that retinoic acid can also affect Ca2+-ATPase by an interaction with the plasma membrane separate from the calmodufin-binding site since other studies from our laboratory have shown that retinoic acid (but not retinol), competes for plasma membrane binding sites with thyroid hormone (12) .
The significance of the action of retinoic acid on calmodulin's stimulation of red cell membrane Ca2+-ATPase activity is twofold. First, these observations support a novel model of calmodulin antagonism that involves a membrane calmodulin-binding site, rather than intetaction of the antagonist directly with calmodulin itself. This mechanism also appears to be involved in the inhibition by specific long chain fatty acids of the stimulation of Ca2+-ATPase by calmodulin (29) . The benzene ring-substituted analogue of all-trans retinoic acid does not inhibit Ca2+-ATPase activity, however, indicating a specific inhibitory effect of the retinoid structure; the effect is not simply a reflection of the fatty acid side-chain of retinoic acid. Second, retinoic acid has discrete actions at the plasma membrane, in addition to those that are genomic and involve the superfamily of nuclear receptors for corticosteroids, thyroid hormone, and the retinoid (30) .
